Abstract
A series of cyclic urea HIV protease inhibitors containing alkynyl-and alkenyl-tethered heterocycles in the P2 region were synthesized. The alkynyl compounds exhibited poor activity against the HIV protease enzyme. However, reduction of the triple bond afforded trans-alkenyl derivatives ( XU348 and XU430) which displayed superb potency (sub-nanomolar K i).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
